In this regard we are very disappointed that the randomization process resulted in a significant imbalance in baseline NSAA scores between the active and placebo cohorts of the participants ages 67 making the 67 age groups noncomparable and likely substantially contributing to the inability to achieve statistical significance said Doug Ingram president and chief executive officer Sarepta